greeksoup/ stock research

Amgen (AMGN) Q1 FY2025 earnings: revenue $8.1 billion, up 9.4% on the year

Amgen Inc. (AMGN) reported revenue of $8.1 billion for Q1 FY2025, the quarter ended 31 March 2025, up 9.4% on the same quarter a year earlier. Net income was $1.7 billion, and diluted earnings per share $3.20. The figures are the company's own, from the 10-Q it filed with the SEC on 2 May 2025.

Revenue
$8.1 billion
+9.4% on the year · -10.3% on the quarter
Q2 FY2023Q1 FY2025
Operating margin
14.5%
13.3% a year earlier
Q2 FY2023Q1 FY2025
Net income
$1.7 billion
+175.9% on the quarter
Q2 FY2023Q1 FY2025
Diluted EPS
$3.20
+175.9% on the quarter
Q2 FY2023Q1 FY2025

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Revenue8,1499,0867,447-10.3%+9.4%
Cost of revenue2,9683,1123,200-4.6%-7.2%
Gross profit5,1815,9744,247-13.3%+22.0%
Gross margin63.6%65.7%57.0%
Research and development1,4861,7241,343-13.8%+10.6%
Selling, general and administrative1,6871,8781,808-10.2%-6.7%
Operating income1,1782,311991-49.0%+18.9%
Operating margin14.5%25.4%13.3%
Interest expense723747824-3.2%-12.3%
Pre-tax income1,973782-68.0+152.3%
Income tax24315545.0+56.8%+440.0%
Effective tax rate12.3%19.8%n/a
Net income1,730627-113+175.9%
Net margin21.2%6.9%-1.5%
Diluted EPS$3.20$1.16-$0.21+175.9%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Operating cash flow1,3914,771689-70.8%+101.9%
Capital expenditure411371230+10.8%+78.7%
Free cash flow9804,400459-77.7%+113.5%
Free cash flow margin12.0%48.4%6.2%
Cash from investing-447-402-217
Cash from financing-4,107-1,407-1,708
Depreciation and amortisation1,3871,3971,399-0.7%-0.9%
Share-based compensation85.0134103-36.6%-17.5%
Dividends paid1,2791,2051,208+6.1%+5.9%
Dividend per share$2.38$2.38$2.250.0%+5.8%
Diluted shares, weighted541m542m536m-0.2%+0.9%
Shares outstanding at period end538m537m536m+0.1%+0.2%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2025Q4 FY2024Q1 FY2024On the quarterOn the yearLast 8 quarters
Shareholders' equity6,2075,8775,022+5.6%+23.6%
Debt57,38160,09964,020-4.5%-10.4%
Operating lease liabilitiesn/a673n/a
Other liabilities25,77925,19023,938+2.3%+7.7%
Total liabilities and equity89,36791,83992,980-2.7%-3.9%
Fixed assets6,6816,5436,002+2.1%+11.3%
Goodwill18,64518,63718,570+0.0%+0.4%
Intangible assets25,72427,69931,372-7.1%-18.0%
Securities held for sale or to maturity8,30211,4869,237-27.7%-10.1%
Cash and equivalents8,81011,9739,708-26.4%-9.3%
Receivables8,1326,7826,776+19.9%+20.0%
Inventory6,7296,9988,724-3.8%-22.9%
Other assets6,3441,7212,591+268.6%+144.8%
Total assets89,36791,83992,980-2.7%-3.9%

Questions

What was Amgen's revenue in Q1 FY2025?

Amgen (AMGN) reported revenue of $8.1 billion for Q1 FY2025, the quarter ended 31 March 2025, up 9.4% on the same quarter a year earlier.

How much did Amgen earn in Q1 FY2025?

Net income for Q1 FY2025 was $1.7 billion, and diluted earnings per share $3.20.

When did Amgen report Q1 FY2025 results?

Amgen filed its 10-Q for the quarter ended 31 March 2025 with the SEC on 2 May 2025.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue6,8466,2386,5946,6526,8396,1056,9866,9038,1967,4478,3888,5039,0868,1499,1799,5579,8668,61810,05410,365
Cost of revenue1,7181,5611,5101,5881,7471,7201,8131,8063,1123,2003,2363,3103,1122,9683,0113,0822,9762,7442,8112,788
Gross profit5,1284,6775,0845,0645,0924,3855,1735,0975,0844,2475,1525,1935,9745,1816,1686,4756,8905,8747,2437,577
Gross margin75%75%77%76%74%72%74%74%62%57%61%61%66%64%67%68%70%68%72%73%
R&D1,3489591,0391,1121,3241,0581,1131,0791,5341,3431,4471,4501,7241,4861,7441,9002,1421,7191,8682,111
SG&A1,4251,2281,3271,2871,5721,2581,2941,3532,2741,8081,7851,6251,8781,6871,6911,7201,9521,6021,7451,680
Operating income2,3042,5002,1762,6602,2301,9212,6842,0211,2719911,9092,0472,3111,1782,6562,5262,7202,6663,5143,710
Operating margin34%40%33%40%33%31%38%29%16%13%23%24%25%14%29%26%28%31%35%36%
Interest expense335295328368415543752759821824808776747723694685653657673653
Pre-tax income2,1311,6751,5312,3921,7483,4421,6141,947852-68.07943,1017821,9731,5683,9211,5142,0842,7684,686
Tax rate11%12%14%10%8%17%15%11%10%n/a6%9%20%12%9%18%12%13%14%18%
Net income1,8991,4761,3172,1431,6162,8411,3791,730767-1137462,8306271,7301,4323,2161,3331,8192,3753,864
Net margin28%24%20%32%24%47%20%25%9%-2%9%33%7%21%16%34%14%21%24%37%
Diluted EPS$3.33$2.68$2.45$3.98$3.00$5.28$2.57$3.22$1.42-$0.21$1.38$5.22$1.16$3.20$2.65$5.93$2.45$3.34$4.37$7.08
Operating cash flow2,8082,1641,9302,9782,6491,0644,1092,7605386892,4593,5714,7711,3912,2804,6841,6032,1894,0024,241
Capital expenditure287190246160340344271248249230238257371411369436642712513587
Free cash flow2,5211,9741,6842,8182,3097203,8382,5122894592,2213,3144,4009801,9114,2489611,4773,4893,654
Buybacks1,4436,3600.00.00.00.00.00.00.0n/an/an/an/an/an/an/an/an/an/an/a
Dividends paid9901,0801,0381,0381,0401,1371,1391,1401,1401,2081,2091,2101,2051,2791,2801,2821,2831,3581,3621,363
Shares outstanding558m534m535m534m534m534m535m535m535m536m537m538m537m538m538m538m539m540m541m541m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 March 2025, filed 2 May 2025: the filing.